ReShape Lifesciences Inc
NASDAQ:RSLS
ReShape Lifesciences Inc
NASDAQ:RSLS
Price:
0.1698 USD
-4.61%
Market Closed
Updated:
Apr 28, 2024
ReShape Lifesciences Inc
Revenue
|
ReShape Lifesciences Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ReShape Lifesciences Inc
NASDAQ:RSLS
|
Revenue
$8.7m
|
CAGR 3-Years
76%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
ReShape Lifesciences Inc
Revenue Breakdown
Breakdown by Geography
ReShape Lifesciences Inc
ReShape Lifesciences Inc
|
Total Revenue:
8.7m
USD
|
|
United States:
7.1m
USD
|
|
Europe:
956k
USD
|
|
Australia:
526k
USD
|
|
Rest Of World:
62k
USD
|
Breakdown by Segments
ReShape Lifesciences Inc
ReShape Lifesciences Inc
Not Available
See Also
What is ReShape Lifesciences Inc's Revenue?
Revenue
8.7m
USD
8.7m
USD
Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Revenue amounts to 8.7m USD.
What is ReShape Lifesciences Inc's Revenue growth rate?
Revenue CAGR 5Y
-1%
-1%
Over the last year, the Revenue growth was -23%. The average annual Revenue growth rates for ReShape Lifesciences Inc have been 76% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
